Interleukin-3, interleukin-8, FMLP and C5a enhance the release of leukotrienes from neutrophils of patients with atopic dermatitis
- PMID: 2045129
- PMCID: PMC1384522
Interleukin-3, interleukin-8, FMLP and C5a enhance the release of leukotrienes from neutrophils of patients with atopic dermatitis
Abstract
The influence of the receptor-specific stimuli interleukin-3 (IL-3), interleukin-8 (IL-8), C5a and formyl-methionyl-leucyl-phenylalanine (FMLP) on the generation of arachidonic acid-derived inflammatory mediators from neutrophils (PMN) has been studied in patients with atopic dermatitis (AD) as well as in healthy, non-atopic volunteers. The release of leukotriene (LT)B4, the omega-oxidation products 20-COOH- and 20-OH-LTB4 and the cysteinyleukotriene LTC4 were measured by reverse-phase HPLC and radioimmunoassay. The incubation of neutrophils with these stimuli led to a significantly higher release of LTB4 and LTC4 in the AD group. The spontaneous leukotriene generation of PMN from patients with AD was on average threefold higher compared to the control group. C5a stimulated the release of LTB4 and its metabolites from atopic cells up to 9 ng in contrast to low amounts from non-atopic cells. Furthermore, FMLP distinctly enhanced the leukotriene release of neutrophils from patients with AD compared to unstimulated cells and to cells of normal donors. IL-3 and IL-8 also significantly stimulated the generation of LTB4 and LTC4 of PMN from atopic patients. Our data emphasize that neutrophils may play an important role in the pathogenesis of AD by an increased responsiveness to receptor-specific stimuli and further suggest that IL-3 and IL-8 influence the acute and chronic inflammatory reactions in patients with AD.
Similar articles
-
Conversion of leukotriene A4 by neutrophils and platelets from patients with atopic dermatitis.Immunology. 1991 Dec;74(4):689-95. Immunology. 1991. PMID: 1664416 Free PMC article.
-
Modulation of leukotriene release from human polymorphonuclear leucocytes by PMA and arachidonic acid.Immunology. 1988 May;64(1):51-9. Immunology. 1988. PMID: 2838420 Free PMC article.
-
Cytokine-induced (interleukins-3, -6 and -8 and tumour necrosis factor-beta) activation and deactivation of human neutrophils.Immunology. 1992 Feb;75(2):281-5. Immunology. 1992. PMID: 1312995 Free PMC article.
-
The treatment of atopic dermatitis and other dermatoses with leukotriene antagonists.Skin Therapy Lett. 2004 Feb;9(2):1-5. Skin Therapy Lett. 2004. PMID: 14749843 Review.
-
A role for leukotriene antagonists in atopic dermatitis?Am J Clin Dermatol. 2001;2(1):1-6. doi: 10.2165/00128071-200102010-00001. Am J Clin Dermatol. 2001. PMID: 11702615 Review.
Cited by
-
Regulatory effects of cytokine production in atopic allergic reaction by gammi-danguieumja.Inflammation. 2004 Oct;28(5):291-8. doi: 10.1007/s10753-004-6053-0. Inflammation. 2004. PMID: 16134003
-
The myeloid switch: immune drivers in atopic dermatitis - roles in pathogenesis and emerging therapeutic targeting.Front Immunol. 2025 Jun 30;16:1608338. doi: 10.3389/fimmu.2025.1608338. eCollection 2025. Front Immunol. 2025. PMID: 40661941 Free PMC article. Review.
-
Leukotriene A4 hydrolase in peripheral leukocytes of patients with atopic dermatitis.Arch Dermatol Res. 1996 Apr;288(4):168-72. doi: 10.1007/BF02505219. Arch Dermatol Res. 1996. PMID: 8967787
-
The creatine-phosphagen system is mechanoresponsive in pancreatic adenocarcinoma and fuels invasion and metastasis.Nat Metab. 2020 Jan;2(1):62-80. doi: 10.1038/s42255-019-0159-z. Epub 2020 Jan 20. Nat Metab. 2020. PMID: 32694686 Free PMC article.
-
Corticosteroid treatment in cystic fibrosis.Arch Dis Child. 1993 Jun;68(6):719-21. doi: 10.1136/adc.68.6.719. Arch Dis Child. 1993. PMID: 8333757 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources